Fifty-four S&P 500 stocks closed at 52-week highs on Friday, July 3, with Moderna posting the strongest one-month run in the group. The breadth spans insurers, biotech names and REITs, while Visa, Johnson & Johnson and AbbVie carry the largest market values among the leaders.
Momentum ran wide across the S&P 500 on Friday, July 3, when 54 of its members traded at their 52-week highs. The advance reached across sectors, from Property & Casualty Insurance and Biotechnology to Multi-Family Residential REITs and Health Care REITs.
Moderna leads the one-month move
Among the stocks at new highs, Moderna outpaced the rest with a 75% return over the past month. The biotech name also stood out on the day, rising 10.0% and closing at $79.76. Over the past year, Moderna is up 178.0%.
Large caps anchor the list
By market capitalization, the biggest names at 52-week highs were Visa, Johnson & Johnson and AbbVie. Visa carried a $654.7 billion market value, followed by Johnson & Johnson at $633.6 billion and AbbVie at $462.1 billion. AbbVie rose 4.0% on the day and is up 21.2% over the past month.
Trefis noted that stocks near 52-week highs often signal momentum and investor conviction, a level that can act as an anchor for expectations and can trigger further institutional buying. But it also cautioned that fundamentals matter when evaluating such names.
Breadth beyond the megacaps
The strength was not confined to the largest companies. Vertex Pharmaceuticals jumped 6.0% to $528.04, while Charles River Laboratories showed a 32.0% one-month gain. A separate Trefis tally counted 56 S&P 500 stocks at 52-week highs as of market close, with Visa, Johnson & Johnson and AbbVie holding the largest market caps in that group.
Trading involves risk.
Risk Disclaimer
